Intellectual Property India Publishes Patent Application for 'Diagnosis, Monitoring, And Treatment Of Conditions Characterized By Intracellular Free Radicals' Filed by Obvia Pharmaceuticals, Ltd.

MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202547085523 A) filed by Obvia Pharmaceuticals, Ltd., Madison, U.S.A., on Sept. 9, for 'diagnosis, monitoring, and treatment of conditions characterized by intracellular free radicals.'

Inventor(s) include Fahl, William; Goesch, Torsten; Goesch, Hannah, Rebecca; and Goesch, Sarah, Ricarda.

The application for the patent was published on Nov. 21, under issue no. 47/2025.

According to the abstract released by the Intellectual Property India: "The invention features the use of coelenterazine, or a close analog, as a systemically administered real-time reporter of ROS or RNS levels in animal cell and organ settings. This real-time measurement can then b...